Is it normal to feel suddenly not hungry after taking Anamorelin for three days?

Anamulin is an oral ghrelin receptor agonist, mainly used to treat cancer-related cachexia (cancer-induced weight loss). Its core function is to enhance the patient's appetite and weight by simulating the effect of ghrelin (ghrelin). Most patients will experience a significant improvement in appetite within the first few days of taking anamorelin, including increased food intake, increased hunger, and a slight recovery in physical energy.

Some patients experience improvement in appetite in the early stages of taking the drug, but suddenly "feel not hungry" or their appetite decreases again three days later. This may be related to individual differences, fluctuations in underlying disease status, changes in mental status, or eating habits. This brief fluctuation does not necessarily mean drug failure or abnormal reaction, but if appetite cannot be restored for a long time, or is accompanied by other symptoms such as fatigue, nausea, bloating, etc., you need to be alert to whether there are other potential problems.

The efficacy of anamorelin is affected by many factors, such as the time of taking the drug on an empty or full stomach, whether it is combined with other drugs that inhibit gastrointestinal function (such as morphine, certain chemotherapy drugs, etc.), or whether there is a gastrointestinal disease. These factors may affect the patient's appetite response. It is recommended that patients take anamorelin at the same time every day on an empty stomach and try to avoid taking it at the same time with drugs that affect gastric motility or appetite.

If a patient suddenly loses appetite after taking anamorelin for three days and does not recover for several days, it is recommended to seek medical treatment in time or contact the attending doctor to rule out whether it is caused by other medications, infection, or disease progression. At the same time, the condition can be improved by adjusting the diet structure and increasing nutritional support. Anamorelin, as an appetite-promoting drug, usually has a stable effect. However, due to large individual differences, it should be flexibly evaluated according to the actual situation, and the dose should be adjusted or combined with other supportive treatments when necessary.

Reference materials:https://www.drugs.com/